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Norwalk virus (NV) is a prototype strain of the genus Norovirus in the family Caliciviridae. The human noroviruses have emerged as major
agents of acute gastroenteritis in all age groups, but there are no vaccines or antiviral agents partly due to the absence of a cell culture system. We
report the generation of cells expressing self-replicating NV RNA (NV replicon) following transfection of NV RNA bearing an engineered
neomycin resistance gene into cell lines of human (Huh-7) or hamster (BHK21) origin. Expression of replicon RNAwas significantly reduced in
the presence of interferon (IFN)-α in a dose-dependent manner in the NV replicon-bearing cells, suggesting a role for innate immunity in the
control of human norovirus replication. This stable NV replicon system should lead to new insights into norovirus replication, virus–host
interactions, and approaches for the treatment of norovirus disease.
© 2006 Elsevier Inc. All rights reserved.Keywords: Norwalk virus; Replicon-bearing cells; Huh-7; Interferon; RNA replicationIntroduction
Caliciviruses are positive strand RNA viruses in the family
Caliciviridae that consists of four genera, Norovirus, Sapo-
virus, Lagovirus, and Vesivirus. Viruses in the genera Noro-
virus and Sapovirus cause gastroenteritis in humans and
animals. Recent studies estimate that noroviruses are respon-
sible for more than 90% of nonbacterial gastroenteritis
outbreaks (Fankhauser et al., 1998) and as many as 23 million
cases of gastroenteritis in the United States each year (Mead
et al., 1999). Norwalk virus (NV), a prototype strain of the
noroviruses, was associated with an outbreak of gastroenteritis
in Norwalk, Ohio, in 1968 (Kapikian et al., 1972). The viral
genome is ∼7.7 kb in length and organized into open reading
frames (ORFs) 1, 2, and 3, that encode an ∼1800-amino-acid
(aa) polyprotein, the major capsid protein (VP1), and a minor⁎ Corresponding author. Fax: +1 785 532 4039.
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doi:10.1016/j.virol.2006.06.006capsid protein (VP2), respectively (Jiang et al., 1993; Xi et
al., 1990). The NV ORF1 polyprotein is processed by the
viral proteinase (Pro) into several nonstructural proteins with
the gene order: N-terminal protein (45 kDa); NTPase
(40 kDa); “3A-like” protein (22 kDa); VPg (16 kDa); Pro
(20 kDa); RNA-dependent RNA polymerase (Pol) (57 kDa)
(Blakeney et al., 2003; Hardy et al., 2002). The structural
proteins, VP1 and VP2, are synthesized from a subgenomic
RNA containing ORFs 2 and 3 (Glass et al., 2000; Jiang et
al., 1992). Calicivirus replication occurs in association with
intracellular membranes and likely proceeds through a minus
strand RNA intermediate that is used as the template for the
synthesis of positive-sense full-length genome and subge-
nomic RNA (Green et al., 2002).
Studies of noroviruses associated with disease in humans
have been hampered by the continued absence of a cell culture
system (Duizer et al., 2004). Two recent advances in norovirus
research include the discovery of a murine norovirus that
grows in a murine macrophage-like cell line (Wobus et al.,
2004), and the demonstration that transfection of a full-length
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promoter) into modified vaccinia Ankara (MVA)-T7 infected
cells allowed the expression of viral proteins and subsequent
NV RNA replication (Asanaka et al., 2005). Here, we report
the generation of a stable RNA replicon system for NV that
functions in both human Huh-7 cells and hamster BHK21
cells, and that circumvents the need for a helper virus. The
replicon-bearing cells expressed NV proteins and RNA and
could be maintained after multiple passages in the presence of
G418. Importantly, the replicon-bearing cells could be
examined for the effects of potential viral inhibitors, and we
provide evidence that NV replication is sensitive to the effects
of exogenous interferon (IFN). Virus replicon systems have
proved an important tool in the investigation of virus–host
interactions (Blight et al., 2000; Foy et al., 2003; Gale and
Foy, 2005), and the availability of a NV replicon provides a
new system in which such interactions can be assessed for the
human noroviruses.Fig. 1. Generation of construct pNV-Neo and analysis of RNA expression in replicon
and the NV replicon construct (pNV-Neo). The location of the GDD motif deleted i
HG23 cells by RT-PCR. Total cellular DNAwas isolated from parental Huh-7 (lane 1
that were designed to amplify the full length neomycin phosphotransferase gene (80
extracted from HG23 cells (at two different passages) with NV-specific primers, NV
Controls (lanes 3 and 4) included PCR analysis (in the absence of RT and with prime
NV positive (lanes 1–6) and negative sense RNA (lanes 7–10). Lanes 1 to 3: positive
Neo (lane 1), the subgenomic RNA of parental NV (lane 2) and the subgenomic RNA
and HG23 cells (lanes 5 and 6, two different passages). Lane 7: RNA transcripts corre
to 10: RNA preparation from Huh-7 (lane 8) and HG23 cells (lanes 9 and 10). For Nor
with MicroPoly(A) purist kit (Ambion).Results
Generation and characterization of NV replicon-bearing cells
Plasmid NV101, which contained a cloned cDNA consensus
sequence of the RNA genome of NV (Fernandez-Vega et al.,
2004), was engineered to encode the neomycin resistance gene
within ORF2 (Fig. 1A). The resulting plasmid was designated
pNV-Neo. A second plasmid, designated pNV-NeoΔGDD, was
engineered to abolish RdRp activity of the viral Pol by deletion
of the GDD motif within the Pol coding sequence. Following
the transfection of RNA transcripts derived from pNV-Neo or
pNV-NeoΔGDD into BHK2, Vero, 293, 293T LLC-PK and
Huh-7 cells, viable cell colonies were subsequently selected in
the presence of G418 (0.5 mg/ml) only in BHK21 cells
transfected with RNA derived from pNV-Neo. The cells were
subjected to cloning by limiting dilution, and two clones (G3
and G6) were chosen for further characterization (data not-bearing cells HG23. (A) Schematic diagram of the genome organization of NV
n construct pNV-NeoΔGDD is indicated. (B) Detection of NV-specific RNA in
) or HG23 (lane 2) cells and PCR was performed with primers Neo-F and Neo-R
4 bp). Lanes 3 to 8 contain RT-PCR products obtained by analysis of total RNA
p35 and NVp36 (470 bp) (lanes 5 and 7) or Neo-F and Neo-R (lanes 6 and 8).
r pair Neo-F and Neo-R) of RNA from HG23 cells. (C) Northern blot analysis of
sense RNA transcript controls representing the full-length RNA encoded in pNV-
encoded in pNV-Neo (lane 3). Lanes 4 to 6: RNA purified from Huh-7 (lane 4)
sponding to the negative sense subgenomic RNA encoded in pNV-Neo. Lanes 8
thern blot analysis, mRNA from Huh-7 or HG23 cells were isolated and enriched
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pNV-Neo proved inefficient in the selection of replicon-bearing
cells, and a strategy was developed in which replicon RNA
purified from G3 cells (passage number 60) was used in the
transfection. Viable Huh-7 cell colonies bearing the NV replicon
were then selected in the presence of G418, and a cell clone
designated HG23 was selected for further study.
A gene-specific PCR assay for the neomycin phosphotrans-
ferase gene was used to verify that the neomycin resistance gene
had not integrated into the cellular DNA of HG23 cells. Total
DNA purified from Huh-7 or HG23 cells was analyzed for the
presence of the gene by PCR (in the absence of RT), and no
PCR products were observed (Fig. 1B, lanes 1 and 2,
respectively). In contrast, analysis of the isolated RNA from
HG23 cells (at two different passages) by RT-PCR yielded an
804-bp product consistent with that expected for the neomycin
resistance gene (Fig. 1B, lanes 6 and 8). In addition, the
presence of NV-specific RNA was confirmed in the two
preparations of HG23 cells by RT-PCR with diagnostic primers
NVp35 and NVp36 (Atmar et al., 1995), that would produce an
expected product of 470 bp (Fig. 1B, lanes 5 and 7). It should
also be noted that RNA purified from the parental Huh-7 cells
was negative for the presence of the neomycin resistance gene
and NV RNA by RT-PCR (data not shown), which was
consistent with their inability to survive in the presence of
G418.
The RNA species produced in HG23 cells were examined by
Northern blot analysis. Sense and anti-sense RNA probes
specific for the NV ORF3 region were hybridized with RNA
that was extracted from HG23 or parental Huh-7 cells and
further enriched with oligo(U) purification. Genomic and
subgenomic RNA controls for the Northern blot included a
full-length RNA transcript (positive sense) derived from
linearized pNV-Neo, and subgenomic-length positive or
negative sense RNA molecules (representing wild type or
replicon NV) derived by transcription from corresponding PCR
products containing an engineered T7 promoter. The full-length
RNA transcript obtained from pNV-Neo was detected as a band
of ∼7.2 kb in size in the Northern blot for positive strand RNA
(Fig. 1C, lane 1). The positive sense subgenomic RNA
transcripts representing wild type NV and replicon NV were
detected as bands sized at ∼2.3 kb and ∼1.8 kb, respectively
(Fig. 1C, lanes 2 and 3). The negative sense subgenomic
replicon RNA control was also detected as a band at ∼1.8 kb
(Fig. 1C, lane 7). The Northern blot analysis for positive strand
RNA showed that RNA purified from the two passages of
HG23 cells contained both genomic and subgenomic sized
RNA species that corresponded in size to the replicon RNA
controls (Fig. 1C, lanes 5 and 6). The same RNA samples
(loaded at 10 times higher concentration) analyzed in a Northern
blot for negative strand RNA showed the presence of a full-
length RNA molecule of the expected length and low to
undetectable levels of a negative sense subgenomic RNA (Fig.
1C, lanes 9 and 10). Negative sense subgenomic RNA was
difficult to detect in BHK21-derived G3 and G6 cells as well,
even when total RNA without oligo(U) enrichment was
analyzed (data not shown). The lower amounts of negativestrand RNA compared to positive strand are an expected feature
of positive strand RNA replication (Blight et al., 2000).
However, it was of interest that negative strand full-length
genomic RNAwas present following oligo(U) enrichment. This
too might be expected in that a replicative form consisting of a
closely associated plus and minus strand has been demonstrated
in cells infected with other positive strand RNA viruses (Pogue
et al., 1994).
Expression of NV proteins in HG23 cells was examined by
immunofluorescence assay (IFA) and Western blot analysis
(Fig. 2). Controls for these experiments included the analysis
of NV proteins expressed in Huh-7 cells infected with MVA-
T7 and transfected with the NV full-length clone NV101.
Hyperimmune serum raised in a guinea pig against recombi-
nant NV ProPol showed a positive signal in the IFA when
reacted with HG23 cells (shown in Fig. 2A, panels 1 and 2 at
high (200×) and low (100×) magnification and with Huh-7
cells infected with MVA/T7 and transfected with NV101 (Fig.
2A, panel 5) (100×). Of interest, discrete areas of localized
antigen expression were observed in the cytoplasm of HG23
cells near and around the nucleus reminiscent of the
vesiculated areas observed in murine norovirus-infected cells
(Wobus et al., 2004) and the perinuclear localization of the
NV N-terminal protein expressed alone in transfected cells
(Fernandez-Vega et al., 2004). The NV ProPol hyperimmune
serum showed no reactivity in the IFA with the parental Huh-7
cells (Fig. 2B, panel 4) or with Huh-7 cells infected with
MVA/T7 (Fig. 2A, panel 6). In addition, preimmune serum
from the same guinea pig did not react with the HG23 cells
(Fig. 2A, panel 3). Hyperimmune sera raised against the NV
ProPol or NTPase detected proteins by Western blot analysis
consistent in observed mass with the mature Pol (57 kDa) and
Pro (19 kDa) or NTPase (40 kDa), respectively, in NV101-
transfected cells infected with MVA/T7 virus (Fig. 2B, lane 2
and Fig. 2C, lane 6). A protein profile similar to that of the
NV101 expression experiment was observed in the Western
blot analysis of three different passages of HG23 cells probed
with the NV-specific ProPol (Fig. 2B, lanes 4–6) or NTPase-
specific sera (Fig. 2C, lanes 2–4). No evidence for NV-
specific proteins were detected in Huh-7 cells (Fig. 2B, lane 3
and Fig. 2C, lane 1) or in Huh-7 cells infected with MVA-T7
(Fig. 2B, lane 1 and Fig. 2C, lane 5). These data show that the
nonstructural proteins are expressed in the replicon-bearing
cells, and that authentic proteolytic processing of the
nonstructural polyprotein encoded in ORF1 likely occurs.
Sequence analysis of the replicon RNA purified from G3 and
G6 cells soon after selection in G418 (less than passage
number [P] 10) found no sequence differences compared to
that of the NV replicon encoded in plasmid NV101. At
passage 60, the RNA from G3 cells was purified and
examined again by sequence analysis. At this later passage,
two nucleotide changes were detected that resulted in two
amino acids changes: one in ORF1 (N-terminal protein) and
one in ORF3 (VP2) (Table 1). Following transfection of the
P60 RNA from G3 cells into Huh-7 cells, additional mutations
were detected in the analyzed P8 RNA that included four
HG23 cell-specific mutations in ORF1 (one amino acid each
Fig. 2. Detection of Norwalk virus protein expression in replicon-bearing cells (HG23) by IFA and Western blot analysis. (A) IFA staining was performed with
preimmunization or post-immunization serum obtained from a guinea pig hyperimmunized with NV recombinant ProPol protein. Panels 1 and 2: HG23 cells reacted
with ProPol post-immunization serum and shown at high (200×) or low (100×) magnification, respectively. Panel 3: HG23 cells reacted with the preimmunization
serum from the same guinea pig. Panel 4: parental Huh-7 cells reacted with the ProPol hyperimmune serum. Panels 5 and 6: Huh-7 cells that were infected with MVA/
T7 and then transfected with pNV101 (Panel 5) or mock-transfected with PBS (Panel 6). (B) Western blot analysis with antibodies specific for the NV ProPol. Lanes 1
and 2: total lysates of Huh-7 cells that were infected with MVA/T7 and then either mock transfected with PBS (Lane 1) or transfected with pNV101 (Lane 2). Lane 3: a
lysate prepared from Huh-7 cells without treatment. Lanes 4–6: lysates prepared from three different passages of HG23 cells. C. Lane 1: a lysate prepared from Huh-7
cells without treatment. Lanes 2–4: lysates prepared from three different passages of HG23 cells (the same samples analyzed above in panel B). Lanes 5 and 6: lysates
from Huh-7 cells infected with MVA/T7 and then either mock transfected with mock PBS and pNV101 after MVA-T7 infection, respectively.
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additional mutations (two amino acids and one silent
mutation) in the ORF3 region (Table 1). No mutations were
observed in the 5′ and 3′ nontranslated regions of HG23
replicon RNA as determined by 5′ and 3′ RACE, respectively.
Both G3 and HG23 cell lines were stable and NV replicon
positive without significant changes in the expression of NV
proteins at least 100 passages (the maximum number we
passaged them so far) in the presence of G418.
Infectivity of RNA isolated from replicon-bearing cells
A colony-forming assay was developed in order to assess
the infectivity of RNA purified from replicon-bearing cells.
Transfection of RNA replicon extracted from HG23 cells intofresh BHK21 cells produced viable cell colonies in the
presence of G418 (Fig. 3B, panel 2), and an enzyme-based
immunostaining technique that used NV ProPol-specific
antiserum confirmed the expression of NV proteins (Fig. 3,
panel 5). Controls for the immunostaining experiments
included an G3 cell monolayer that showed positive reactivity
with the ProPol serum (Fig. 3, panel 6), and an BHK21
monolayer that showed no reactivity with the same serum
(Fig. 3, panel 8). The number of colonies selected after
transfection of BHK21 cells with replicon RNA isolated from
HG23 cells was higher than that after transfection of BHK21
cells with RNA transcripts (pNV-Neo) (compare Fig 3B,
panels 1 and 2). The copy number (genome equivalents) of
the RNA transcripts and RNA replicon (from HG23 cells)
transfected into BHK21 cells in Fig 3B was calculated as
Table 1
Sequence analysis of NV replicon RNA from G3 and HG23 cells
Open reading
frame (ORF)
Genomic
position of
nucleotide a
Position of amino
acid (viral protein) b
NV101 G3
(P60)
HG23
(P8)
ORF1 311 103 (N-term) TGG
(Trp)
CGG
(Arg)
CGG
(Arg)
792 263 (N-term) GAA
(Glu)
GAA GGA
(Gly)
2061 686 (NTPase) GAA
(Glu)
GAA GGA
(Gly)
3515 1171 (Pro) ATG
(Met)
ATG GTG
(Val)
4079 1359 (Pol) GAG
(Glu)
GAG AAG
(Lys)
ORF3 7052 35 (VP2) TAT
(Tyr)
TAT CAT
(His)
7196 83 (VP2) GCT
(Ala)
GCT ACT
(Thr)
7372 142 (VP2) AAT
(Pro)
AAT AAC
(Pro)
7577 210 (VP2) AAT
(Asn)
GAT
(Asp)
GAT
(Asp)
a Nucleotide are numbered according to sequence of NV virus genome as
follows: ORF1 (nt 5–5374) and ORF3 (nt 6950–7588), encoding a large
polyprotein (viral nonstructural proteins) and VP2, respectively.
b Amino acid residues are numbered according to location in the
corresponding ORF. The nucleotide of interest is underlined and its location
in the codon of the translated ORF is shown. N-term: N-terminal protein. Pro:
proteinase. Pol: polymerase.
467K.-O. Chang et al. / Virology 353 (2006) 463–4732.6 × 1011 (1 μg of RNA) and 8.0 × 108, respectively by qRT-
PCR. Because the infectivity of calicivirus RNA purified from
virions (or infected cells) is severely reduced by the treatment
of RNA with proteinase K (Black et al., 1978; Chang et al.,
2002; Herbert et al., 1997), we examined whether treatment ofFig. 3. Colony formation assay in BHK21 cells. BHK21 cells were transfected with R
replicon-bearing HG23 cells. G418-resistant cell colonies were then selected in the p
RNA transcripts from pNV-Neo, and lanes 3 and 4: total RNA from HG23 cells after
RNA transfection and incubation with G418. Colonies were visualized by crystal vio
used ProPol antibody (panels 5–8). Panels 1 and 3: BHK21 cells at 2 weeks follo
transfection with PBS, respectively. Panels 2 and 4: BHK21 cells at 2 weeks followi
(mock control) or proteinase K, respectively. Panels 5 and 7: the same cells as pa
procedure). Panels 6 and 8: immunostaining assays on confluent G3 and BHK cellsthe replicon RNA with this enzyme decreased its infectivity in
the colony-forming assay. Treatment of the replicon RNA with
proteinase K (100 μg/ml) at 37 C for 4 h prior to transfection
abolished the selection of cell colonies in the presence of
G418 (Fig. 3B, panel 4). This result suggests that the
infectivity of replicon RNA purified from cells is enhanced by
the presence of the VPg protein.
Effect of IFN-α on the NV replicon
Recent studies have reported that innate immunity plays
an important role in the control of murine norovirus infection
(Karst et al., 2003; Wobus et al., 2004), so we examined
whether NV replication in Huh-7 cells was sensitive to the
effects of IFN-α. The HG23 cells were treated with
increasing concentrations of human IFN-α (up to 20 U/ml),
and its effect on protein expression was monitored by IFA
(Fig. 4A) and Western blot analysis (Fig. 4B). In addition, a
qRT-PCR assay developed by Kageyama et al. (2003) was
used for a comparative analysis of RNA levels present in
mock-treated or IFN-α-treated replicon-bearing cells. The
addition of IFN-α to HG23 cells inhibited NV protein
expression in a dose-dependent manner (Figs. 4A and B),
while the cells themselves showed no toxic effects of the
treatment (data not shown). Additional controls in the
Western blot analysis showed that the expression of STAT1
increased proportionately to the concentrations of IFN-α,
while the β-actin loading control remained constant (Fig. 4B,
lanes 2–7). The levels of NV-specific RNA as measured by
qRT-PCR decreased also in a dose-dependent manner (Fig.
4C). The presence of 20 U/ml of IFN-α for 72 h resulted in
nearly complete clearance of the replicon proteins and RNA,
and the effective dose of IFN-α for reducing NV proteinNA derived either by in vitro transcription from pNV-Neo or by isolation from
resence of the antibiotic. (A) RNA preparations used in the transfection. Lane 2:
treatment with proteinase K (lane 3) or PBS (lane 4). (B) Colony formation after
let staining (panels 1–4) or by an enzyme-based immunostaining technique that
wing transfection with RNA transcripts derived from pNV-Neo and or mock
ng transfection with RNA extracted from HG23 cells that was treated with PBS
nels 2 and 4 (cells were stained with crystal violet after the immunostaining
, respectively.
Fig. 4. Effect of IFN-α treatment on the NV replicon in HG23 cells. HG23 cells were treated with increasing concentrations of IFN-α (0 to 20 U/ml) and examined after
72 h. (A) IFA staining (using the ProPol antibody) of HG23 cells incubated with the indicated concentrations of IFN-α. (B) Western blot analysis of HG23 cell lysates
incubated with varying concentrations of IFN-α and analyzed with antibodies specific for NV ProPol protein (upper panel), STAT1 (middle panel) and β-actin (lower
panel). In all panels, lane 1: lysates from nontreated Huh-7 cell lysates, and lanes 2 to 7: lysates from HG23 cells treated with 20, 10, 5, 2, 1 and 0 U/ml of IFN-α,
respectively. Lanes 8 and 9: lysates from Huh-7 cells infected with MVA/T7, and then transfected with pNV101 or PBS, respectively. (C) Copy numbers of NV
genome per cell as determined by qRT-PCR. Bars represent the copy number/cell (log10) of NV genome and symbols ♦ represent the percent reduction (compared to
cells without treatment, 0 IFN-α) of NV genome in HG23 cells treated with varying concentrations of IFN-α, respectively. A comparison of the total replicon RNA
purified from nontreated HG23 cells with a standard curve (generated by the dilution of RNA transcripts derived from pNV-Neo) showed that total RNA replicon was
usually present in a calculated range of 1000–3000 copies per cell.
468 K.-O. Chang et al. / Virology 353 (2006) 463–473(ProPol) and genome copies in HG23 cells to 50% (ED50) of
that observed in the nontreated (mock) control at 72 h was
calculated to be approximately 2 U/ml (Figs. 5B and C). The
sensitivity of the NV replicon to human IFN-α was observed
also in the BHK21-based G3 cells, but the ED50 was ten
times higher (20 U/ml) (data not shown).
The NV replicon does not interfere with the induction of an IFN
response in HG23 cells
We next examined whether the presence of the NV
replicon in Huh-7 cells affected the ability of the cells to
respond to the induction of IFN by Sendai virus (SeV).
Similar studies of the HCV replicon system in Huh-7 cells
had led to the identification of strategies utilized by HCV to
subvert the innate immune response (Foy et al., 2003).Reporter plasmids for luciferase expression under control of
the DNA promoters ISRE (pISRE-TA-luc), NF-kB (pNF-kB-
TA-luc), or IFN-β (pIFNβ-TA-luc) were transfected into Huh-
7 cells or HG23 cells and expression of luciferase was
measured in the presence or absence of SeV infection. The
pRL-CMV (for renillar luciferase under CMV promoter) was
co-transfected in all experiments to control the efficiency of
the transfection and standardize luciferase expression levels.
In some experiments, the reporter plasmid was co-transfected
with pCI-NVcap, which would express the NV major capsid
protein VP1. Analysis of the effect of SeV infection on cells
transfected with the reporter plasmids showed a marked
similarity between the Huh-7 and HG23 cells in their overall
response to the induction of IFN by SeV. The luciferase
expression increased up to 30-fold in both parental Huh-7 and
HG23 cells transfected with pISRE-TA-luc and infected with
Fig. 5. Luciferase expression under the control of DNA elements of ISRE, NF-kB or IFN-β in Huh-7 and HG23 cells with or without Sendai virus (SeV) infection.
One-day-old (∼90% confluent) Huh-7 or HG23 cells in 12-well plates were transfected with each reporter plasmid (pISRE-TA-Luc, pNF-kB-TA-Luc or pIFNb-TA-
Luc) and pRL-CMV with or without pCI-NVCap (VP1). After 24 h of the transfection, the cells were infected with SeVor mock infected with medium. Luciferase
expression was measured at 18 h after SeV infection, and data presented as fold increase of luciferase expression by SeV infection. The luciferase expression (firefly
luciferase) was normalized against the expression level of the renilla luciferase. Bars represent standard deviations of at least 3 independent experiments.
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the IFN-β promoter was induced up to 100-fold by SeV
infection regardless of the presence of NV replicon (Fig. 5).
There were minimum responses of luciferase expression
under control of the NF-kB element in both Huh-7 and HG23
cells (Fig. 5). Co-transfection of pCI-NVCap (which provided
the NV VP1 capsid protein not present in the replicon) with
the reporter plasmids did not result in significant differences
in luciferase expression (Fig. 5).
Discussion
In the absence of a permissive cell culture system for the
human noroviruses, the availability of a stable cell line
expressing NV RNA would allow the study of virus and host
interactions and provide a platform for screening anti-viral
compounds. This report describes the generation of a NV RNA
replicon system in BHK21 and Huh-7 cells. A neomycin
resistance gene was engineered into the VP1-encoding region of
ORF2, disrupting expression of an intact VP1, but preserving
the likely subgenomic promoter, an intact ORF3, and the
genomic 3′-end. The presence of NV-specific RNA was
demonstrated in the replicon-bearing cells by Northern blot
analysis and RT-PCR. Analysis of NV-specific proteins in the
replicon-bearing cells showed expression of NV antigen in the
cytoplasm and provided evidence for authentic proteolytic
processing of the NV nonstructural polyprotein in cells. The NV
replicon-bearing cells (G3 and HG23) showed growth kinetics
similar to those of the parental BHK21 and Huh-7 cells, with no
apparent cytotoxic effects associated with endogenous expres-
sion of the NV genome. Sequence analysis of the replicon RNA
of G3 and G6 BHK21-based cells showed that no adaptive
mutations had occurred immediately after selection and in the
early passages. In contrast, the replicon RNA of HG23 Huh-7-
based cells accumulated several mutations in ORF1 and ORF3
soon after selection (P8). It remains important to elucidatewhether the mutations facilitate efficient replication of replicon
RNA in Huh-7 cells (HG23).
The replicon RNA was infectious in that it allowed the
selection of new antibiotic-resistant cells when isolated and
transfected back into fresh cells. The “infectivity” of the
replicon RNA was abolished by treatment with proteinase K.
Furthermore, the efficiency of generating antibiotic-resistant
cell colonies by replicon RNA purified from the replicon-
bearing cells was higher than that of RNA transcripts
derived from pNV-Neo. A likely explanation for this latter
observation was that the presence of VPg enhanced the
infectivity of the replicon RNA, as shown for the viral RNA
of other caliciviruses (Black et al., 1978; Chang et al., 2002;
Herbert et al., 1997). Of interest, uncapped RNA transcripts
derived from pNV-Neo did not produce viable cell colonies
following transfection and incubation of cells in the presence
of G418 (data not shown). This observation was consistent
with studies of RNA transcripts generated in the FCV and
PEC calicivirus reverse genetics systems from cDNA clones,
in which uncapped RNA was not infectious (Chang et al.,
2005; Sosnovtsev and Green, 1995). The NV VPg interacts
with host translation initiation factor eIF3, and thus, may
play a role in translation of the viral RNA (Daughenbaugh et
al., 2003). The infectivity of the NV replicon RNA in both
hamster and human cells suggests that the NV VPg can
interact with the translation machinery of both species.
The stable NV replicon system allowed the initiation of
studies to investigate NVand host interactions relating to innate
immunity. A similar cell-based RNA replicon system for HCV
allowed the identification of certain evasion mechanisms of
intracellular host defense likely used by the virus during
infection (Blight et al., 2000; Foy et al., 2003; Gale and Foy,
2005). The NS3/4 protein of HCV was shown to block IRF-3
activation, thereby inhibiting the production of IFN-β in
response to SeV infection (Foy et al., 2003). The NS5A protein
of HCV, an inhibitor of PKR, was an important site where
470 K.-O. Chang et al. / Virology 353 (2006) 463–473adaptive mutations occurred that allowed higher levels of
replication by the HCV replicon (Blight et al., 2000; Gale and
Foy, 2005). Although evasion mechanisms have been docu-
mented for HCV, the HCV replicon was shown to be susceptible
to the effects of exogenous IFN in vitro (Blight et al., 2000; Guo
et al., 2003). Furthermore, IFN has been a major component in
treatment strategies for HCV infection (Feld and Hoofnagle,
2005). In contrast, the West Nile virus (WNV) replicon was
resistant to exogenous IFN in vitro (Guo et al., 2003, 2005), and
a effective mechanism to disrupt the STAT1 pathway was linked
to the nonstructural proteins (Guo et al., 2003, 2005). In this
study, we showed that IFN-α efficiently cleared the NV replicon
in vitro. The ED50 of IFN-α for the NV replicon in HG23 cells
(2 U/ml) was comparable to that for HCV in its Huh-7-based
replicon system (Blight et al., 2000; Guo et al., 2003). Fur-
thermore, the incubation of IFN-α with HG23 cells induced the
expression of STAT1, which suggested a role for the STAT1
pathway in the inhibitory effects of IFN-α on the RNA replicon.
It was noteworthy that STAT-1 increased in IFN-α-treated
HG23 cells, which would argue against an NV mechanism to
degrade the STAT1 protein as documented for certain other
viruses (Samuel, 2001). The presence of the NV replicon in
Huh-7 cells failed also to inhibit the ability of the cell to mount
an innate immune response upon infection with SeV as
measured with reporter plasmids pISRE-TA-luc and pIFNβ-
TA-luc. Taken together, these data suggest that NV is sensitive
to exogenous IFN and, moreover, may lack an active evasion
strategy to counteract host cellular defenses involving STAT1-
mediated pathways. There have been no reports of a direct
mechanism used by other caliciviruses for the control of the
innate immune response in cells. Viruses known to lack anti-
innate immunity mechanisms (such as IFN-sensitive viruses)
often show severe growth restriction in target cells (Durbin et
al., 1996; Garcia-Sastre et al., 1998), and it is possible that the
inability of NV to exert such mechanisms might be related to its
fastidious characteristics in cell culture. An understanding of
these virus–host factors involving cellular antiviral defense may
facilitate the development of a fully permissive cell culture
system for the human noroviruses. In addition, it remains
important to elucidate whether interactions occur between the
NV replicon and other cellular defense pathways that do not
involve IFN.
Although norovirus infection is generally considered self-
limiting and a short-term illness, recent findings showed that the
infection could last longer than several days or even several
months in immunocompromised patients (Green et al., 2001;
Nilsson et al., 2003). The treatment options for norovirus
infection are limited partly due to the absence of screening
systems for antiviral drugs. Interferons are well studied and
widely used to treat many viral infections including HCV (Feld
and Hoofnagle, 2005). Our data suggest a potential therapeutic
application of IFN-α to prolonged norovirus infection, but
additional studies will be needed to clarify this activity in vivo.
The availability of the first helper virus-free NV replicon system
should lead to new insights into norovirus replication, the host
cell response to infection, and approaches for the treatment of
norovirus disease.Materials and methods
Cells and reagents
The BHK2, Vero, 293, 293TandHuh-7 cells weremaintained
in Dulbecco's minimal essential medium containing 10% fetal
bovine serum and antibiotics [chlortetracycline (25 μg/ml),
penicillin (250 U/ml), and streptomycin (250 μg/ml)] (DMEM-
C). LLC-PK cells (ATCC) were maintained in Eagle's minimal
essential medium (EMEM) containing 5% fetal bovine serum
and the antibiotics. Recombinant IFN type 1 (human IFN-
αA + IFN-αD fusion protein) was purchased from Serotec Inc.
(Raleigh, NC). SeV was purchased from Charles Liver
Laboratories (Wilmington, MA). Antibodies specific for
STAT1 (nonphosphorylated) or β-actin were obtained from
Cell Signaling Tech (Danvers, MA).
Plasmid construction and generation of region-specific
antisera
Standard recombinant DNA methods were used for
construction of plasmids. The consensus full-length clone of
NV, NV101, has been described previously (Fernandez-Vega et
al., 2004). For the construction of pNV-Neo, the neomycin
phosphotransferase (neo) gene was amplified by PCR from the
pIRESNeo vector (Clontech, Mountain View CA) with primers
5′-ataattggatccTATGGGATCGGCCATTGAAC-3′ (Neo-NV-
F) and 5′-ttaattaccggtTCAGAAGAACTCGTCAAG-3′ (Neo-
NV-R). The PCR product was digested with BamHI and AgeI
(underlined), and cloned into the corresponding sites of the
NV101 plasmid. The resulting construct contained the
neomycin resistance gene engineered into the 5′-end region
of the ORF2 so that the expressed product would contain the
first 33 aa of the NV VP1 fused in frame with neomycin
phosphotransferase (with an engineered termination codon)
(Fig. 1A). The viral Pol active site GDD in pNV-Neo was
deleted by site-directed mutagenesis (Promega, Madison, WI)
using primers, CATGTCATATTTCTCATTTTATGA-
GATTGTGTCAACTGACATAG (N-ΔGDD-F) and CTATGT-
CAGTTGACACAATCTCATAAAATGAGAAATATGA-
CATG (N-ΔGDD-R), generating the pNV-NeoΔGDD plasmid.
Sense and anti-sense VP2 gene (ORF3)-specific probes were
designed to detect either positive or negative strand NV genomic
RNA. The VP2 gene was PCR amplified from NV101 using
primers ATGGCCCAAGCCATAATTGG (N-VP2-F) and
TCATCGCCTATTATTTGC (N-VP2-R), and cloned to
pCR2.1 downstream of T7 promoter using a TA cloning kit
(Invitrogen, Calrsbad, CA).We chose two recombinant plasmids
with opposite orientations to the T7 promoter.
Nucleotides (nts) 1712–2287 and 3000–4000 of the Nor-
walk virus genome were each cloned into pET-28a(+)
(Novagen, Madison WI) that would express partial NV protein
(NTPase and ProPol) sequences fused to a His6-tag at the N-
terminus. After purification of each protein, antisera specific for
the recombinant proteins were raised in guinea pigs as
described previously (Sosnovtsev et al., 1998). The ORF2 of
the NV genome was amplified from NV101 with forward
471K.-O. Chang et al. / Virology 353 (2006) 463–473primer: 5′-AGGCCTACGCGTCTCGAGGAAATGAT-
GATGGCGTCTAAGGACGCTACATCAAGC-3′ (with an
incorporated XhoI site underlined) and reverse primer 5′-
GCTCGAGACGCGTTTATCGGCGCAGACCAAGCC-
TACCTCTTGCC-3′ (with an incorporated MluI site under-
lined). The resulting PCR fragment was digested with XhoI and
MluI and cloned into the corresponding restriction enzyme sites
of the pCI (Promega) eukaryotic expression vector. The
resulting clone was designated pCI-NVCap.
Transfection of RNA transcripts and selection of
neomycin-resistant cells
RNA transcripts were synthesized with the mMessenger
mMessage in vitro transcription kit (Ambion, Austin, TX) using
restriction enzyme (MluI)-linearized plasmids (pNV-Neo or
pNV-NeoΔGDD) as templates. All transfections were per-
formed with Lipofectamine 2000 (Invitrogen) in 6-well tissue
culture plates (containing BHK2, Vero, 293, 293T, LLC-PK,
and Huh-7 cells) with 1 μg of RNA per well. After the
transfection, neomycin, G418 (Cellgro, Herndon, VA), was
added at concentrations of 0.5–1 mg/ml to DMEM-C. Medium
was removed and replaced with fresh DMEM-C containing the
antibiotic every 3 days.
Detection of Norwalk virus RNA and proteins
RT-PCR. RT-PCR for detecting the neomycin resistant gene
or NV genome was performed using primers Neo-F (5′-
ATGGGATCGGCCATTGAAC-3′) and Neo-R (5′-TCAGAA-
GAACTCGTCAAG-3′) or NVp35 and NVp36 (Atmar et al.,
1995), respectively. Northern blot analysis. Northern blot
analysis was conducted with the reagents and conditions
specified in the NorthernMax-Gly kit (Ambion) and biotinylated
RNA probes. The RNA transcripts of NV ORF3 were prepared
as anti-sense and sense probes designed to detect either positive
or negative strand NV genomic RNA, respectively. For the
generation of RNA controls in the Northern blot analysis, RNA
was produced by in vitro transcription (Ambion) from the
following DNA templates: pNV-Neo linearized withMlu1; PCR
products corresponding to the pNV-Neo subgenomic region; and
PCR products corresponding to the NV101 subgenomic region.
The PCR products contained an engineered T7 promoter in
either the forward or reverse orientation to produce positive or
negative sense subgenomic RNA, respectively. Immunofluor-
escence assay (IFA). The ProPol serum was added to methanol-
fixed monolayers of cells, and the binding of antibodies was
detected with fluorescein isothiocyanate (FITC)-conjugated,
affinity-purified goat antibodies to guinea pig immunoglobulin
G (IgG) (ICNBiomedicals, Aurora, OH) as described previously
(Chang et al., 2002). Western blot analysis. Protein samples of
Huh-7 and HG23 cells were prepared in SDS-PAGE sample
buffer containing 2% 2-mercaptoethanol, and sonicated for 20 s.
The proteins were resolved in a 10% Novex Tris–Bis gel
(Invitrogen) and transferred to a nitrocellulose membrane. The
membranes were probed with guinea pig antibodies specific for
the ProPol and NTPase proteins, and the binding of theantibodies was detected with peroxidase-conjugated, goat anti-
guinea pig IgG (Sigma, St. Louis, MO). Following incubation
with a chemiluminescent substrate (SuperSignal West Pico
Chemiluminescent Substrate, Pierce biotechnology, Rockford,
IL), the signals were detected with X-ray film. Controls for IFA
and Western blot analysis included Huh-7 cells transfected with
NV101 following MVA-T7 infection (Wyatt et al., 1995). The
MVA-T7 virus was a gift from Dr. Bernard Moss, NIAID, NIH.
Sequence analysis.The templates for sequence analysis included
the RNA replicon of early passage number of G3 and G6 cells
(both lower than passage number [P] 10), P60 of G3 cells (which
was used in the transfection of Huh-7 cells for selection of the
HG23 cells) and P8 of HG23 cells. The RNAwas amplified by
RT-PCR and the PCR products were gel-purified and sequenced
directly. Primers used in the RT-PCR and sequence analysis are
available upon request. The 5′ and 3′ ends of the RNA replicon
of HG23 cells (P8) were determined by the 5′ and 3′ RACE
system (Invitrogen), respectively. Real-time qRT-PCR. The
quantity of NV genome in the replicon-bearing cells was
measured by real-time qRT-PCR with the One-step Platinum
qRT-PCR kit (Invitrogen), following an established protocol
with and GI-specific primers and FAM-labeled G1 probes
(Kageyama et al., 2003) as described previously. For quantity
control of cellular RNA, qRT-PCR for the β-actin was
performed as described previously (Spann et al., 2004). For
qRT-PCR, the total RNA in cells (in 6-well plates) was extracted
with the RNeasy kit (Qiagen, Valencia, CA). Each RNA sample
was prepared from a standardized the same number of cells
(∼3 × 106) to calculate NV genomic RNA level per cell. A
standard concentration curve was generated with serial dilutions
of RNA transcripts derived from pNV-Neo in each experiment to
calculate the total number of genome copies present. The relative
genome copy number per cell (RNA level) was calculated by
dividing the total number of genome copies present by the
number of cells in the experiment.
Colony formation assay in BHK21 cells
The replicon RNA was purified from HG23 cells as
described above and transfected into 1-day-old BHK21 cells
with Lipofectamine 2000. Controls included transfection of
RNA transcripts derived from pNVneo as well as the addition
of replicon RNA to BHK21 cells in the absence of
lipofectamine. The transfection mixture was removed after
24 h and DMEM-C containing G418 (0.5 μg/ml) was added.
In some experiments, the replicon RNA was treated with
proteinase K (100 μg/ml) or PBS only at 37 C for 4 h and
purified with the RNeasy kit prior to transfection into BHK21
cells. The DMEM-C containing G418 was replaced every 2 or
3 days up to 3 weeks. When colonies became visible (usually
at 2 weeks following transfection), the cells were fixed with
4% formalin and stained with crystal violet. In some
experiments, the cells were fixed with 4% formalin,
permeabilized with 0.5% Triton X-100, and analyzed in an
immunostaining procedure that employed ProPol antiserum
and peroxidase-conjugated, goat anti-guinea pig IgG (Sigma).
Insoluble TMB (Invitrogen) was used as a substrate to
472 K.-O. Chang et al. / Virology 353 (2006) 463–473visualize antibody binding. Following immunostaining, cells
were then stained with crystal violet to further facilitate the
visualization of colonies.
Treatment of NV-harboring cells with IFN-α
The effect of IFN-α on the NV replicon was examined at
concentrations ranging from 1 to 20 U/ml (for HG23 cells) or 1
to 100 U/ml (for G3 cells). Varying concentrations of IFN-α
were added to 1 day old, 80–90% confluent HG23 or G3 cells,
and the cells were analyzed for viral protein and genome
expression at 24, 48, 72 or 96 h after treatment. The NV protein
and genome expression levels were examined by IFA and
Western blot analysis and qRT-PCR, respectively, as described
above. Western blot analysis included the detection of STAT1
and β-actin using antibodies to STAT1 and β-actin, respec-
tively, as described above except that a peroxidase-conjugated,
goat anti-rabbit IgG (Sigma) was used. The inhibitory effect of
IFN-α on the NV replicon was calculated as the concentration
of IFN-α that resulted in 50% reduction of NV genome (ED50)
as detected by qRT-PCR.
Promoter-luciferase assay for IFN synthesis and response
elements
Plasmids, pISRE-TA-Luc and pNF-kB-TA-Luc were pur-
chased from Clontech. The pIFNβ-TA-Luc was engineered by
replacing the ISRE in pISRE-TA-Luc with the IFN-β
promoter (−183 to +2) using restrictions sites, KpnI and
BglII. The IFN-β promoter was amplified with RT-PCR
reaction using primers IFNB-F, AATTAAGGTACCAAAATG-
TAAATGACATAGGAAAAC (with an incorporated KpnI site
underlined) and IFNB-R AATTAAAGATCTATGTTGACAA-
CACGAACAGTGTC (with an incorporated BlgII site under-
lined), and total RNA extracted from Huh-7 cells as a
template. The induction of firefly luciferase gene expression
was achieved by infecting Huh-7 parental or HG23 cells with
SeV. Because the majority of the NV capsid gene was deleted
in pNV-Neo, the plasmid, pCI-NVCap was co-transfected with
the reporter plasmids in some experiments to provide the NV
VP1 capsid protein in trans to examine whether VP1 (present
in authentic viral infection) might affect interferon induction.
One-day-old (∼90% confluent) Huh-7 or HG23 cells in 12-
well plates were transfected with each reporter plasmid
(pISRE-TA-Luc, pNF-kB-TA-Luc or pIFNb-TA-Luc) and
pRL-CMV with or without pCI-NVCap. The pRL-CMV (for
renillar luciferase under CMV promoter, Promega) served as a
control for the efficiency of the transfection and for
standardization of luciferase expression levels. Cells were
incubated for 24 h before SeV (200 HA U/ml) or mock
medium was added. After an additional 18 h, cells were
harvested for analysis of luciferase expression. The luciferase
assay was carried out with the Dual Glo luciferase assay
system (Promega) in a luminometer (Promega). The luciferase
expression (firefly luciferase) from each reporter plasmid was
normalized against the expression level of the renilla
luciferase encoded in pRL-CMV.Acknowledgments
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